Brain tryptophan perturbation in hepatic encephalopathy: implications for effects by neuropsychoactive drugs in clinical practice.
Bengtsson
F
F
Department of Clinical Pharmacology, Lund University Hospital, Sweden.
Bergqvist
P B
PB
Apelqvist
G
G
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012701:Serotonin / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D014364:Tryptophan / Q000378:metabolism*
D011619:Psychotropic Drugs; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D014364:Tryptophan